BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8497718)

  • 21. Comparative study of aztreonam in gram-negative pneumonia versus a therapeutic regimen that includes an aminoglycoside. Spanish Study Group.
    Marco V; Gobernado M; Santos M; Rabinad E
    Chemotherapy; 1989; 35 Suppl 1():81-8. PubMed ID: 2659295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative trial of aztreonam versus gentamicin in the treatment of urinary tract infections.
    Waller DA; Kendall SW; Whelan P
    Int Urol Nephrol; 1992; 24(3):221-7. PubMed ID: 1399377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical evaluation of aztreonam for serious gram-negative bacterial infections.
    Raz R; Flatau E; Sudarsky M; Keness J
    Chemioterapia; 1988 Feb; 7(1):42-5. PubMed ID: 3378275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1987). II. Background of patients].
    Kosakai N; Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1990 Jun; 43(6):954-67. PubMed ID: 2232149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical experience with aztreonam in Germany and Austria.
    Stille W; Gillissen J
    Rev Infect Dis; 1985; 7 Suppl 4():S825-30. PubMed ID: 3909342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aztreonam in the treatment of urinary tract infection.
    Childs SJ
    Am J Med; 1985 Feb; 78(2A):44-6. PubMed ID: 3881948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aztreonam versus cefamandole in the treatment of urinary tract infections.
    Giamarellou H; Koratzanis G; Kanellakopoulou K; Galanakis N; Papoulias G; el Messidi M; Daikos G
    Chemioterapia; 1984 Apr; 3(2):127-31. PubMed ID: 6543431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of aztreonam in the treatment of patients with renal failure.
    Sion ML; Pyrpasopoulos M; Nicolaidis P; Papagianni C; Tsurutsoglu G
    Rev Infect Dis; 1991; 13 Suppl 7():S652-4. PubMed ID: 2068477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aztreonam: worldwide overview of the treatment of patients with gram-negative infections.
    Henry SA; Bendush CB
    Am J Med; 1985 Feb; 78(2A):57-64. PubMed ID: 3881950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative study of aztreonam and cefamandole in the treatment of serious urinary tract infections.
    Tsouroutsoglou W; Sion ML; Stathopoulos GA; Kapoulas S; El-Messidi M; Paradelis AG
    Methods Find Exp Clin Pharmacol; 1983; 5(6):385-90. PubMed ID: 6684719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Well-controlled comparative study on aztreonam and cefoperazone in the treatment of complicated urinary tract infections].
    Ohmori H; Kumon H; Kumamoto Y; Sakai S; Niijima T; Kishi H; Ohkoshi M; Kawamura N; Naide Y; Nishiura T
    Jpn J Antibiot; 1986 Jan; 39(1):24-56. PubMed ID: 3517407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carumonam versus ceftazidime: in vitro activity, pharmacokinetics in elderly patients, safety and therapeutic efficacy in the treatment of complicated urinary tract infections.
    Naber K; Kees F; Denk K; Bauernfeind A; Grobecker H
    Chemioterapia; 1987 Jun; 6(2 Suppl):517-8. PubMed ID: 3334613
    [No Abstract]   [Full Text] [Related]  

  • 33. Aztreonam compared with gentamicin for treatment of serious urinary tract infections.
    Sattler FR; Moyer JE; Schramm M; Lombard JS; Appelbaum PC
    Lancet; 1984 Jun; 1(8390):1315-8. PubMed ID: 6145024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. UTIs and two new antibiotics in the elderly.
    Jones SR; Kimbrough R
    Geriatrics; 1988 Jul; 43(7):49-52, 55-8. PubMed ID: 3290058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized comparison of aztreonam and cefuroxime in gram-negative upper urinary tract infections.
    Friman G; Cars O; Bäck E; Beckman H; Carlsson M; Forssell J; Fredlund H; Neringer R; Odenholt-Tornqvist I; Rydén C
    Infection; 1989; 17(5):284-9. PubMed ID: 2689345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aztreonam in the treatment of urinary tract infections: a multicenter trial.
    Martelli A; Cortecchia V; Ventriglia L
    Chemotherapy; 1989; 35 Suppl 1():8-14. PubMed ID: 2659294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized clinical trial of aztreonam and aminoglycoside antibiotics in the treatment of serious infections caused by gram-negative bacilli.
    DeMaria A; Treadwell TL; Saunders CA; Porat R; McCabe WR
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1137-43. PubMed ID: 2679368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nephrotoxicity and ototoxicity of aztreonam versus aminoglycoside therapy in seriously ill nonneutropenic patients.
    Moore RD; Lerner SA; Levine DP
    J Infect Dis; 1992 Apr; 165(4):683-8. PubMed ID: 1552197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [An Italian multicenter study on the efficacy and tolerability of aztreonam in the treatment of urinary tract infections].
    Martelli A; Cortecchia V; Ventriglia L
    Clin Ter; 1988 May; 125(3):191-201. PubMed ID: 2973940
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapeutic activity of aztreonam in the treatment of acute and chronic urinary infections].
    Ranno S; Bellotti MG; Raimondi A; Minaldi G
    Minerva Urol Nefrol; 1986; 38(1):65-9. PubMed ID: 3738680
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.